who is not a good candidate for glp 1 GLP-1 medications are changing the conversation around weight and metabolic health, but they're everyone. Swipe to find out if you might be candidate, what the science says, and what Qualifying for GLP-1 Weight Loss:

Decoding GLP-1: A Guide for Friends and Family of Those On The Pen

Expert guidance on managing side effects, choosing nutrient-dense foods, and creating sustainable meal plans for optimal results with GLP-1 medications.

This Lean Cuisine meal is made with no artificial flavor for a satisfying frozen bowl

Novo Nordisks challenge to Regen Doctors promotional claims for compounded semaglutide led the telehealth clinic to voluntarily withdraw its superiority and safety claims.

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

I am pleased to re-share this great work from our Technical R&D teams who recently published in Journal of Peptide Science